Loading clinical trials...
Loading clinical trials...
IIT2021-01-Shiao-CSF1Ri: Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
Conditions
Interventions
Pembrolizumab
Radiation Therapy
+1 more
Locations
1
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Start Date
November 17, 2023
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
April 20, 2026
NCT07040891
NCT07547774
NCT06257264
NCT06492759
NCT03488693
NCT06253871
Lead Sponsor
Stephen Shiao
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions